Headlines

Korea's medical tourism industry is on the cusp of its next leap, driven by artificial intelligence (AI) and anti-aging care converging to reshape treatment across specialties. Panelists at the Medicon Black Roundtable on Tuesday said Korea already has skilled medical staff and technology and AI now makes possible what wasn't before. Hosted by The Korea Times and the Korea Medical Tourism Promotion Association (KMTPA), the roundtable brought together specialists from Korea's five key medical tourism fields: ophthalmology, plastic surgery, dermatology, dentistry and health checkups. Panelists examined how AI and anti-aging could fuel Korea's medical tourism leap, from diagnosis to treatment. "Combine Korea's clinical strengths with AI, K-beauty, wellness and its national brand, and medical tourism can go beyond simply attracting foreign patients," said Kim Jae-kyoung, managing director of Content and Business Planning at The Korea Times. With anti-aging drawing growing interest,

Korea's medical tourism industry is on the cusp of its next leap, driven by artificial intelligence (AI) and anti-aging care converging to reshape treatment across specialties. Panelists at the Medicon Black Roundtable on Tuesday said Korea already has skilled medical staff and technology and AI now makes possible what wasn't before. Hosted by The Korea Times and the Korea Medical Tourism Promotion Association (KMTPA), the roundtable brought together specialists from Korea's five key medical tourism fields: ophthalmology, plastic surgery, dermatology, dentistry and health checkups. Panelists examined how AI and anti-aging could fuel Korea's medical tourism leap, from diagnosis to treatment. "Combine Korea's clinical strengths with AI, K-beauty, wellness and its national brand, and medical tourism can go beyond simply attracting foreign patients," said Kim Jae-kyoung, managing director of Content and Business Planning at The Korea Times. With anti-aging drawing growing interest,

In a development that blurs the line between synthetic materials and living tissue, researchers have unveiled a new class of self-assembling, 3D-printable materials that closely mimic the architecture and behavior of biological tissues. Known as jammed interconnected bilayer emulsions, or JIBEs, these materials can be produced in remarkable quantities—up to deciliter-scale volumes within minutes—and contain […]

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with Rentosertib (known as ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial (NCT07687459, CTR20262475) at Peking Union Medical College Hospital, while Shanghai Pulmonary Hospital has also enrolled its first patient on the same day.

Tim Bradshaw / Financial Times: The AI boom is fueling a resurgence in VC bets in “moonshot” sectors such as BCI; Dealroom says non-AI deeptech funding has topped $150B since the start of 2024  —  Tech investors are rediscovering the kind of long-shot sci-fi bets that helped build Silicon Valley.

Korea's medical tourism industry is on the cusp of its next leap, driven by artificial intelligence (AI) and anti-aging care converging to reshape treatment across specialties. Panelists at the Medicon Black Roundtable on Tuesday said Korea already has skilled medical staff and technology, and AI now makes possible what wasn't before. Hosted by The Korea Times and the Korea Medical Tourism Promotion Association (KMTPA), the roundtable discussion brought together specialists from Korea's five key medical tourism fields: ophthalmology, plastic surgery, dermatology, dentistry and health checkups. Panelists examined how AI and anti-aging could fuel Korea's medical tourism leap, from diagnosis to treatment. "Combine Korea's clinical strengths with AI, K-beauty, wellness and its national brand, and medical tourism can go beyond simply attracting foreign patients," said Kim Jae-kyoung, managing director of Content and Business Planning at The Korea Times. With anti-aging drawing growing

arXiv:2609.10197v1 Announce Type: new Abstract: We show that on any closed orientable real-analytic Riemannian surface, any smoothly immersed closed immortal curve-shortening flow converges to a unique non-constant closed geodesic.

arXiv:2609.09735v1 Announce Type: new Abstract: Healthcare systems, mental health, and public well-being are increasingly affected by cyberbullying and harmful online interactions. This paper presents CareGuard, an early-warning framework designed to support healthcare-driven mental health protection and proactive online safety through the detection of cyberbullying-related content using advanced natural language processing techniques. CareGuard integrates zero-shot semantic labeling with fine-tuned transformer-based models, including BERT, DistilBERT, and RoBERTa, to enable robust and context-aware classification across sensitive cyberbullying categories. To improve efficiency and reduce unnecessary computation in healthcare-oriented monitoring settings, the framework incorporates an emotion-aware filtering mechanism alongside cosine similarity-based semantic screening, allowing the system to focus on semantically relevant and emotionally salient content. Experimental results on

arXiv:2609.09533v1 Announce Type: new Abstract: Clinician review of every AI output is often proposed as a safeguard in mental healthcare, but vigilance research suggests this approach fails at scale and may paradoxically reduce safety. Drawing on our experience deploying an AI coaching tool across 350,000+ conversations between therapy sessions, we describe how we arrived at a three-layer human-on-the-loop oversight framework combining preventive design, real-time monitoring, and continuous clinician evaluation. We show how specific findings from clinical review drove iterative improvements, and offer practical recommendations for mental health professionals evaluating AI systems.

Hair loss affects nearly half of all men and up to a third of women worldwide, yet the treatments available to them have barely changed in decades. Now, a comprehensive review published in Materials Today Bio argues that a quiet revolution is underway at the intersection of materials science and dermatology: intelligent microneedle systems capable […]

Sarah Perez / TechCrunch: Apple unveils a new Health app with Apple Intelligence, featuring an Insights tab, “readiness” and Health Age metrics, and more, rolling out later in 2026  —  Alongside the new Apple Watch Series 12 and Ultra 4, Apple on Wednesday introduced a redesigned Apple Health app …

Intravenous gene therapy extended lifespan, reduced neurological symptoms, and improved disease markers in a Sandhoff disease cat model, supporting further investigation of systemic AAV gene therapy for this disorder. The post Gene Therapy Extends Lifespan and Reduces Symptoms in Sandhoff Disease Cat Model appeared first on GEN - Genetic Engineering and Biotechnology News.

In a two-year head-to-head trial, researchers found that two very different dietary approaches produced similar changes in body weight. A Mediterranean-style eating plan adapted to Southern food preferences helped participants lose about as much weight as WeightWatchers over two years, but it produced substantially greater improvements in reported diet quality. The comparison was part of [...]

Mutations are changes in the molecular "letters" that make up DNA, the genetic blueprint for cells. Mutations build up with age in every cell when DNA is damaged or when cells make mistakes in fixing or copying it.

Zac Hall / 9to5Mac: Apple unveils the Apple Watch Series 12 and Ultra 4, with a new S11 chip, upgraded health tracking, an Audio Intelligence feature, a readiness feature, and more  —  Apple Watch Series 12 and Apple Watch Ultra 4 are official.  Apple has announced its two new Apple Watch models as part of its product event today.

When surgeons remove a portion of a cancerous lung, one of the most frustrating complications they can face is air. A persistent leak from the lung’s cut surface or staple lines — known as prolonged air leak — keeps chest tubes in place far longer than anyone would like, extends hospital stays, inflates costs, and […]

An AI-designed drug, rentosertib, reduced biological age markers by up to six years in a small study, offering potential insights into treatments for ageing.

Mutations are changes in the molecular "letters" that make up DNA, the genetic blueprint for cells. Mutations build up with age in every cell when DNA is damaged or when cells make mistakes in fixing or copying it. Most mutations are harmless, but when they disrupt genes, they can cause cancer and other diseases.

From algorithms to patient outcomes — lessons from one of the first randomized trials of AI in medicine  NatureMedicine Needs to Get Serious About AI  The AtlanticThink Machines Will Replace Doctors? See What’s Happening in These 3 Medical Specialties  inc.comCan AI fix health care? In the chaos of emergency rooms, the technology comes up short  STATSTETHOSCAPE  Telegraph India

From algorithms to patient outcomes — lessons from one of the first randomized trials of AI in medicine  NatureMedicine Needs to Get Serious About AI  The AtlanticThink Machines Will Replace Doctors? See What’s Happening in These 3 Medical Specialties  inc.comCan AI fix health care? In the chaos of emergency rooms, the technology comes up short  STATSTETHOSCAPE  Telegraph India

Blood cancer charities want NHS England’s blanket rule on second stem cell transplants changed to reflect modern practice and opinion.

EpilepsyGTx, a biotechnology company developing gene therapies for refractory epilepsy, and Viralgen, a leading contract development and manufacturing organization (CDMO) specializing in recombinant adeno-associated virus (AAV) gene therapies, today announced a partnership to support production of EpilepsyGTx's lead investigational gene therapy program targeting patients with focal refractory epilepsy (FRE), EPY201, ahead of first-in-human clinical trials.

FDA accepted a priority review for lonvo-z, a one-time CRISPR treatment for hereditary angioedema, with a decision target of March 10, 2027.

Past research has noted that socioeconomic status is a part of a web of correlations that include wealth, intelligence, education, lifestyle choices, and longevity. Untangling all of that to make definitive pronouncements on what exactly drives the observed variation in human life span has proven challenging. It is a reasonable assumption, based on animal studies, that lifestyle choices and consequent degree of physical fitness are the primary factor determining late life survival, however. Here, researchers take a more subtle approach to data analysis and conclude that socioeconomic and demographic status has very little influence on individual longevity. This is much as we might expect if lifestyle choice related to fitness is the primary influence, as will continue to be the case until the first therapies […]

Screening compound libraries for effects on aging in short-lived species has grown to become a significant area of interest in the aging research community. As a general rule, discoveries are modest in effect size, and largely take the form of novel ways to influence the beneficial maintenance and repair activities (such as autophagy) triggered by calorie restriction, heat, cold, and other forms of stress. These responses have a much larger effect on life span in short-lived species than in long-lived species, so in the long run are not all that interesting. Nonetheless, considerable effort has been made to find ways to make this screening process more efficient and automated. Research equipment has been constructed to house tens of thousands of nematode worms and use machine […]

A new robotic system is drawing blood in adult patients, but its real-world impact may depend on how often it skips difficult veins.

arXiv:2609.07610v1 Announce Type: cross Abstract: We convert black-box clinical prediction models for tabular data into standalone nomograms that can be audited term by term. PRiSM (Partial Responses in Structured Models) takes the shape of each effect and interaction from the source model, not merely which variables mattered, and lets the outcome select and weight them. We tested this in 50,356 heart transplant recipients, with validation in a later era than training. Nomograms from all 5 source models - a public clinical risk score, logistic regression, neural networks, random forests and extreme gradient boosting - met a prespecified noninferiority criterion for discrimination before any further simplification, and generally preserved calibration and clinical net benefit. Those from the 3 machine-learning models showed no detectable difference in discrimination from de novo generalized additive and explainable boosting models, exceeded neural additive models, and carried fewer

arXiv:2609.05547v1 Announce Type: new Abstract: Breast cancer diagnosis commonly considers individual nuclear morphological characteristics, whereas their joint organization is less frequently evaluated. We developed the Morphological Network Disruption Index (MNDI), a patient-level measure of morphological abnormality relative to a benign reference state. Using the Wisconsin Diagnostic Breast Cancer dataset, ten nuclear characteristics were represented as network nodes, with MNDI summarizing disruption across 45 pairwise feature configurations. Performance was evaluated using repeated stratified five-fold cross-validation. Malignant lesions exhibited substantially higher MNDI than benign lesions (mean: 3.454 vs. 1.165; p = 2.94e-69). MNDI achieved an AUC of 0.941 (95% CI: 0.918-0.961), with 85.9% sensitivity and 91.6% specificity. A classifier using network-derived descriptors achieved an AUC of AUC of 0.928 +/- 0.024. Independent evaluation in the BreaKHis histopathology cohort

arXiv:2609.05453v1 Announce Type: new Abstract: Excitable and oscillatory responses are widespread in cell signaling, but how these arise in the same system is unclear. We propose a minimal model of a saddle node bifurcation on an invariant circle, where slow fluctuations modulate transitions between excitable and oscillatory states, and noise drives excitability. Fitting the model to cell signaling data from embryonic stem cells reveals that these cells operate close to the bifurcation. Proximity to the bifurcation allows the cell to tune different dynamic states, suggesting a general principle for versatile cell signaling.

arXiv:2609.05453v1 Announce Type: cross Abstract: Excitable and oscillatory responses are widespread in cell signaling, but how these arise in the same system is unclear. We propose a minimal model of a saddle node bifurcation on an invariant circle, where slow fluctuations modulate transitions between excitable and oscillatory states, and noise drives excitability. Fitting the model to cell signaling data from embryonic stem cells reveals that these cells operate close to the bifurcation. Proximity to the bifurcation allows the cell to tune different dynamic states, suggesting a general principle for versatile cell signaling.

Pharmaceutical companies have embraced artificial intelligence in drug research almost universally, yet few company executives expect AI to actually make drugs succeed, according to a Citi survey released on Tuesday. “The biggest risk to the AI-powered drug discovery thesis is not that AI fails to accelerate discovery,” said John Yung, head of Asia healthcare research at the US investment bank. “The stronger risk is that acceleration does not translate into better drugs or higher probability of...

arXiv:2609.08485v1 Announce Type: new Abstract: Whether artificial intelligence pays off for the firms that build it into their products is hard to establish, because AI innovation is itself hard to observe. The medical technology sector is a rare exception: an AI-enabled device must obtain clearance from a national health authority before it can reach a patient, leaving a dated, firm-attributable record of AI innovation output that can be observed directly rather than proxied. We exploit this setting with a three-stage recursive model estimated on a novel firm-level dataset linking FDA premarket clearances, USPTO patents, Scopus publications, and Orbis financials, tracing the full innovation chain from external collaboration through AI device introduction to firm performance. We find that external AI research collaboration is a robust driver of AI device introduction across firm sizes and estimators, with a larger effect for small firms, consistent with external knowledge ties

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive approach to uncover new drug targets, today announced it has been awarded funding through Innovate UK's Investor Partnership Grant, jointly provided by Innovate UK and Empirical Ventures.

One of the above images is real; the other is AI-generated. Can you tell which is which? The images depict intestinal polyps, often benign growths on the inside of the colon or rectum. Polyps are usually removed because some can develop into bowel cancer over time.

In a finding that could reshape how ornamental plant breeders harness radiation to create novel varieties, researchers in Iran have mapped the precise dose-dependent effects of gamma irradiation on two popular cultivars of Begonia rex, one of the world’s most beloved foliage plants. The study, published in BMC Plant Biology, provides the first detailed account […]

The game, 'Build the Wall,' filtered classic block-stacking mechanics through the Trump administration's immigration policies.

In a 50-year follow-up study, men with low cardiovascular risk in their 40s maintained their functional capacity, happiness and quality of life better than others as they aged.

Elderly mice on the popular weight-loss drug semaglutide aged slower and lived longer, mimicking the longevity effects of caloric restriction. The post Could GLP-1 Drugs Help You Live a Longer, Healthier Life? appeared first on SingularityHub.

Researchers from the University of Miami Miller School of Medicine and collaborating institutions have published a comprehensive review examining the rapidly evolving field of intra-arterial stem cell therapy for ischemic stroke, highlighting its potential to improve recovery for patients who continue to face disability despite major advances in stroke treatment.

Sponsored content brought to you by Artificial intelligence is dramatically accelerating early drug discovery. Models can screen chemical space, predict structures, optimize properties, and propose new molecules at speeds that were unimaginable […] The post AI Drug Discovery Hits a New Bottleneck: Experimental Validation appeared first on GEN - Genetic Engineering and Biotechnology News.

A breakthrough pancreatic cancer drug won approval. They still struggle to access it  STATOncologists say newly approved pancreatic cancer drug is a breakthrough for treatment  Healthcare BrewPancreatic cancer drug may hold promise for lung cancer as well, early study suggests  ABC News - Breaking News, Latest News and VideosFDA approves landmark pancreatic cancer drug that's shown to improve survival  WUSA9David Gandara: Daraxonrasib Marks a Major Advance in Pancreatic Cancer Care  Oncodaily

A breakthrough pancreatic cancer drug won approval. They still struggle to access it  STATOncologists say newly approved pancreatic cancer drug is a breakthrough for treatment  Healthcare BrewPancreatic cancer drug may hold promise for lung cancer as well, early study suggests  ABC News - Breaking News, Latest News and VideosFDA approves landmark pancreatic cancer drug that's shown to improve survival  WUSA9David Gandara: Daraxonrasib Marks a Major Advance in Pancreatic Cancer Care  Oncodaily

Zack Zwiezen / Kotaku: The White House has quietly removed Build The Wall, a Tetris clone on its arcade.gov website, after Tetris said it takes “copyright infringement very seriously”  —  It seems the Trump administration doesn't want to tempt a lawsuit from The Tetris Company

Bone repair depends on skeletal progenitor cells (SPCs) moving to injured areas and developing into bone-forming cells, but how these cells respond to their surroundings remains unclear.

It’s time for human doctors to get serious about AI.

Trump admin's propaganda "arcade" hits some apparent legal limits.

Cellular senescence has long been one of biology’s most paradoxical phenomena. In healthy tissue, senescent cells—those that have permanently exited the cell cycle in response to stress, DNA damage, or telomere shortening—act as a safeguard against cancer, halting division before damage can accumulate. Yet as these cells linger, they secrete inflammatory signals that can, over […]

The field of regenerative medicine is gaining momentum. Mesenchymal stem cells (MSCs) remain central to this field, with expanding applications as direct therapies and as producers of MSC-derived extracellular vesicles (MSC-EVs). This article examines the biological and regulatory factors shaping their promise. The post Regenerative Medicine in the Bronze Age: MSCs and MSC-EVs Leading the Way appeared first on GEN - Genetic Engineering and Biotechnology News.

“Build the Wall” was pulled days after the White House launched its “arcade.” | Screenshot: The Verge The White House has taken down its racist Tetris ripoff days after launching a website dedicated to "arcade games," as spotted earlier by Kotaku. The Tetris clone, called "Build the Wall," involved stacking different-sized blocks to prevent a "zombie border siege." It's not clear why the White House removed the title, though the Tetris Company previously said that it's looking into the situation. "For more than 40 years, Tetris has brought people together across generations and cultures through play and joy," Tetris spokesperson Kerri Brusca told The Verge last week. "The objective of the game has always been to stack with purpose to clear … Read the full story at The Verge.

For nearly a decade, the Beacon platform has advanced from integrated single-cell cloning to earlier productivity, product-quality, and stability measurements, with AI-assisted clone evaluation pointing toward the next step. Bringing richer evidence forward helps teams focus resources on the candidates most likely to succeed. The post Measuring Cell Line Development Quality Within Days of Single-Cell Cloning, Not Months Later appeared first on GEN - Genetic Engineering and Biotechnology News.

Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.

Traditional gene editing rewrites DNA. But a new approach, called epigenome editing, aims to treat the molecular scars we collect throughout our lives.

Six proteomic aging clocks found rentosertib lowered predicted biological age in 42 lung fibrosis patients. The smaller dose gave the broadest signal.

Micah Barkley / Bloomberg: Forus, which uses AI to help patients get prescribed drugs more quickly by navigating steps like insurance coverage, raised a $150M Series C at a $3B valuation  —  Healthcare automation startup Forus has raised $150 million at a $3 billion valuation just months after completing a previous funding round.

I recently competed in the British Transplant Games in Sheffield, as the event reached its 48th year.1 More than 1000 transplant recipients and live donors took part, and hundreds of volunteers supported. I’ve always encouraged exercise as part of health, especially for people with health conditions. But since this year’s games I’m also encouraging people to register their decisions on organ donation and sign up to be a stem cell donor.23The event shone with community. Children whose organs had been failing were running, laughing, and thriving. Siblings bonded over sport after coping with more turmoil than any child should bear. Their parents connected with others who had shared experiences.There was a standing ovation as donor families entered for the opening ceremony. I listened to powerful stories from people at the games—people determined to make something positive from the grief of losing a loved one, by allowing organ and tissue donation....

Study Suggests AI-Generated Drug Could Slow Aging  GizmodoIntegration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment  NatureEarly Data Indicates an A.I.-Generated Drug Could Slow Aging  The New York TimesInsilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too  WSJInsilico's IPF candidate rentosertib shows anti-aging promise  FirstWord Pharma

Study Suggests AI-Generated Drug Could Slow Aging  GizmodoIntegration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment  NatureEarly Data Indicates an A.I.-Generated Drug Could Slow Aging  The New York TimesInsilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too  WSJInsilico's IPF candidate rentosertib shows anti-aging promise  FirstWord Pharma

In children with metachromatic leukodystrophy, early gene therapy preserved motor function and survival in long-term follow-up.

Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature publishes landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events that enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community.

Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature publishes landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events that enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community.

Traditional gene editing rewrites DNA. But a new approach, called epigenome editing, aims to treat the molecular scars we collect throughout our lives.

What’s the Face/Off?I mean AI enhanced faces. It’s your dream face, a visage with no pimples or wrinkles, possessing gorgeous cheekbones, the perfect nose and jawline, and immaculate symmetry, whatever you desire.But now plastic surgeons say that they are increasingly being asked by patients to replicate them in real life.Some 15% of members of the British Association of Aesthetic Plastic Surgeons (BAAPS) say they have met patients who show up for consultation appointments with AI beautified faces.1Facing reality?“We can improve and enhance features, but we cannot rewrite anatomy or guarantee a digitally perfect outcome,” BAAPS president Nora Nugent said.“The image can feel like a realistic representation of what patients could look like after surgery, but it may bear very little relation to what is anatomically or surgically possible.”Unlike traditional inspiration images, AI generated photographs can be particularly powerful because they depict the patient themselves—creating the

A new study suggests Insilico Medicine’s AI-designed lung drug may slow biological aging, though more research is needed.

AI-Discovered Drug Reverses Aging Markers In Study, Biotech Says  Bloomberg.comEarly Data Indicates an A.I.-Generated Drug Could Slow Aging  The New York TimesIntegration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment  NatureInsilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too  WSJAI-designed drug candidate reverses biological age in clinical study  News-Medical

AI-Discovered Drug Reverses Aging Markers In Study, Biotech Says  Bloomberg.comEarly Data Indicates an A.I.-Generated Drug Could Slow Aging  The New York TimesIntegration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment  NatureInsilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too  WSJAI-designed drug candidate reverses biological age in clinical study  News-Medical

In a development that could reshape how surgeons train for some of the most dangerous operations in medicine, a multidisciplinary team of neurosurgeons and engineers in Spain has built and validated a patient-specific, 3D-printed skull base model that replicates the delicate anatomy encountered during endoscopic endonasal surgery, including the internal carotid arteries, the optic nerves […]

Without brain surgery guided by live AI assistance, Rhys Hibbert could have lost his sight to a tumour.

A man has lived for a record nine months with a transplanted pig kidney while waiting for a human transplant.

Researchers at Weill Cornell Medicine and Hospital for Special Surgery have discovered the stem cells—unspecialized cells that can develop into specific cell types—that give rise to the body's tendons and ligaments, the tissues connecting muscles and bones.

A genetically modified kidney from a pig has worked in a patient with kidney failure for nine months—the longest period yet recorded—US doctors have reported.The transplant kept Tim Andrews, 66, free of dialysis for 271 days, and demonstrated for the first time that a pig kidney can be used as a temporary “bridge” until a human transplant becomes available, according to a case study report published in the Lancet.1Andrews had kidney failure caused by type 2 diabetes. He had just a 9% chance of receiving a human kidney within five years, against a more than 40% risk of dying or being removed from the waiting list for a transplant, the researchers noted.The pig kidney he received worked for nine months before it failed and was removed. After a short period of dialysis, he received another kidney from a deceased human donor.Researchers at Mass General Brigham hospital, Massachusetts—who carried out the...

Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, today announced the publication of a new study conducted in collaboration with an international team of scientists from Harvard Medical School, Stanford University, The Broad Institute, RWTH Aachen University, Peking University and Westlake University.

Researchers at Weill Cornell Medicine and Hospital for Special Surgery have discovered the unspecialized stem cells that give rise to the body's tendons and ligaments, the tissues connecting muscles and bones.

Blood samples from a small lung-disease trial have been run through six independently built ageing clocks, and all six returned the same answer: the patients on the drug looked biologically younger than the patients on placebo. “More lifetimes than humanity lost in all the wars ever fought. If you manage to add 3 years to […] This story continues at The Next Web

Cade Metz / New York Times: Insilico, which uses AI to accelerate drug discovery, says early data shows that rentosertib, a drug developed to treat a chronic lung disease, could slow aging  —  Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition.

Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature publishes landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events that enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community.

Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature publishes landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events that enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community.

Dr. Annu Navani shares four low-cost longevity habits rooted in sleep, stress management, nutrition and resistance training for a longer healthspan.

A miniature human bladder with flowing urine revealed that a standard UTI antibiotic struggled where lab tests said it should work.

Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.

Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.

For three years, the case for ambient artificial intelligence in healthcare was told through one scene: a physician

A team of engineers and surgeons in China has built a handheld surgical robot that brings robotic dexterity to laparoscopic surgery in a package small enough to hold in one hand, and their prototype has now shown laboratory performance figures that could challenge the dominance of the multimillion-dollar operating room robots that currently define surgical […]

Lung cancer tumors that respond well to targeted drugs often harbor a hidden population of cells that the drugs cannot touch, and new research reveals that neighboring support cells actively reprogram those survivors into a drug-resistant state. A study published in the Journal of Experimental & Clinical Cancer Research shows that mesenchymal stromal cells educated […]

The Gerontological Society of America has thrown its institutional weight behind a sweeping new review of respiratory vaccine evidence, endorsing findings released on September 2, 2026 by the Vaccine Integrity Project in collaboration with the American Medical Association. The endorsement arrives at a moment of heightened public scrutiny of immunization policy, and it places one […]

That number on your vehicle's battery signals four key facts about it. Ignore it at your peril - batteries are less interchangeable than you may think.

Kidney organoids grown from human stem cells have transformed how researchers study kidney development and disease, but they have always shared one stubborn flaw: they lack blood vessels. Now a team at Maastricht University in the Netherlands has unveiled a 3D printed microfluidic chip that coaxes lab-grown kidney organoids to develop their own primitive capillary […]